NF-KAPPA-B AND TRANSCRIPTIONAL CONTROL OF RENAL EPITHELIAL-INDUCIBLE NITRIC-OXIDE SYNTHASE

被引:48
作者
AMOAHAPRAKU, B
CHANDLER, LJ
HARRISON, JK
TANG, SS
INGELFINGER, JR
GUZMAN, NJ
机构
[1] UNIV FLORIDA,COLL MED,DEPT PHARMACOL,GAINESVILLE,FL 32610
[2] UNIV FLORIDA,COLL MED,DIV NEPHROL HYPERTENS & TRANSPLANTAT,GAINESVILLE,FL 32610
[3] MASSACHUSETTS GEN HOSP,DIV PEDIAT NEPHROL,BOSTON,MA
[4] HARVARD UNIV,SCH MED,BOSTON,MA
关键词
D O I
10.1038/ki.1995.337
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Expression of the inducible isoform of nitric oxide synthase (iNOS) is subject to strict tissue specific transcriptional control. Recently, the NF-kappa B/Rel family of transcription factors, and particularly c-rel, was shown to mediate bacterial lipopolysaccharide (LPS) induction of iNOS in macrophages. Since LPS is only a weak inducer of iNOS in most nonimmune cells, we investigated the role of NF-kappa B in the regulation of iNOS expression in mouse renal epithelial cells. We report that LPS activates NF-kappa B in renal epithelium, but that this is not sufficient for induction of iNOS activity. The NF-kappa B complexes activated by LPS in renal epithelium differ from those in macrophages in that they lack c-rel, which may explain the absence of iNOS induction in renal epithelium. Conversely, LPS and interferon-gamma (IFN) synergize to induce renal epithelial iNOS. Functional iNOS promoter analysis indicate that this synergistic induction requires NF-kappa B. We conclude that NF-kappa B is necessary but not sufficient for the induction of renal epithelial iNOS expression, and that in contrast to macrophages, c-rel does not appear to play a major role in the regulation of renal epithelial iNOS.
引用
收藏
页码:674 / 682
页数:9
相关论文
共 33 条
  • [1] Amoah-Apraku Bismark, 1993, Journal of the American Society of Nephrology, V4, P544
  • [2] BOGDAN C, 1993, J IMMUNOL, V151, P301
  • [3] CHANDLER LJ, 1994, ALCOHOL GLIAL CELLS, V27, P195
  • [4] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [5] COONEY AJ, 1993, TRANSCRIPTION FACTOR, P49
  • [6] DING AH, 1988, J IMMUNOL, V141, P2407
  • [7] THE CANDIDATE ONCOPROTEIN BCL-3 IS AN ANTAGONIST OF P50/NF-KAPPA-B-MEDIATED INHIBITION
    FRANZOSO, G
    BOURS, V
    PARK, S
    TOMITAYAMAGUCHI, M
    KELLY, K
    SIEBENLIST, U
    [J]. NATURE, 1992, 359 (6393) : 339 - 342
  • [8] CHARACTERIZATION OF A RENAL TUBULAR EPITHELIAL-CELL LINE WHICH SECRETES THE AUTOLOGOUS TARGET ANTIGEN OF AUTOIMMUNE EXPERIMENTAL INTERSTITIAL NEPHRITIS
    HAVERTY, TP
    KELLY, CJ
    HINES, WH
    AMENTA, PS
    WATANABE, M
    HARPER, RA
    KEFALIDES, NA
    NEILSON, EG
    [J]. JOURNAL OF CELL BIOLOGY, 1988, 107 (04) : 1359 - 1368
  • [9] HIRAI H, 1992, ONCOGENE, V7, P1737
  • [10] NITRIC-OXIDE - A NEW ENDOGENOUS IMMUNOMODULATOR
    LANGREHR, JM
    HOFFMAN, RA
    LANCASTER, JR
    SIMMONS, RL
    [J]. TRANSPLANTATION, 1993, 55 (06) : 1205 - 1212